RE: Good support at 15p14 Jan 2020 20:03
Thanks guys for the debate/ views/ interpretations.
A full re-read of RNS, I agree, is a lot longer than I first understood. Teach me for not proof reading in depth before jumping in, getting spiked (bad) when this broke on the crazy triple % ride up.
Yes, company has massive $B potential in the future, but a while off yet.
1. It is anticipated that this new Phase III trial will commence in 2020, following agreement of the trial design between Avion, ImmuPharma and the FDA. -> > So 2020 is about setting up the parameters of the trial & getting sign off from FDA.
2. Following recruitment of patients (to include US, Europe and elsewhere).->> How long does it take to identify all these patients with the bio marker they are after & recruit onto the trial?
3. It is envisaged that this will be a 52-week trial. - >> 52 weeks AFTER points 1 + 2.
Kicking myself a bit here, but will take it as a lesson learned. Read & re read the RNS. Will be re-evaluating my investment in the morning. Looks like I need to go & re-coup losses elsewhere. Come back later.
TLW better be kind to me in the morning...all I can say.
FF